Article Details

FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly's Tanezumab

Retrieved on: 2021-03-25 19:18:45

Tags for this article:

Click the tags to see associated articles and topics

FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly's Tanezumab. View article details on hiswai:

Excerpt

Three days after U.S. Food and Drug Administration (FDA) staff raised safety concerns over Pfizer's and Eli Lilly's NGF osteoarthritis drug tanezumab, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up